State Bank of India:企業のM&A・事業提携・投資動向

◆英語タイトル:State Bank of India - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
◆商品コード:DATA904C1380
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:207
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:インド
◆産業分野:サービス
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD700 ⇒換算¥103,600見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD1,050 ⇒換算¥155,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

State Bank of India – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Summary

Marketline’s State Bank of India Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by State Bank of India since January2007.

Synopsis

Marketline’s Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes State Bank of India’s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by State Bank of India. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope

- Provides intelligence on State Bank of India’s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by State Bank of India and its subsidiaries since 2007.
- Information about key financial and legal advisors for State Bank of India’s financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons to buy

- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about State Bank of India’s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors’ business structure and growth strategies.

【レポートの目次】

Table of Contents
COMPANY OVERVIEW AND KEY FACTS 2
TABLE OF CONTENTS 5
LIST OF TABLES 7
LIST OF FIGURES 7
TARGETS AND PARTNERS 8
MERGERS & ACQUISITIONS 9
Mergers and Acquisitions – Overview 9
Mergers and Acquisitions – Deal reports 10
CORPORATE VENTURING 38
Corporate Venturing – Overview 38
Corporate Venturing – Deal reports 39
PARTNERSHIP 76
Partnership – Overview 76
Partnership – Deal reports 77
CAPITAL RAISING 101
Capital Raising – Overview 101
Capital Raising – Deal reports 102
DIVESTMENTS 118
Divestments – Overview 118
Divestments – Deal reports 119
PRIVATE EQUITY & OWNERSHIP 192
Private Equity and Ownership – Deal reports 192
APPENDIX 197
Contact Us 197
About MarketLine Financial Deals Database 197
Deal Definition and Methodology 199
About MarketLine 206

List of Tables
Table 1: State Bank of India M&A volume and value trend (2014-YTD2018)
Table 2: State Bank of India M&A activity by geography (2014-YTD2018)
Table 3: State Bank of India corporate venturing volume and value trend (2014-YTD2018)
Table 4: State Bank of India corporate venturing by geography (2014-YTD2018)
Table 5: State Bank of India partnership volume and value trend (2014-YTD2018)
Table 6: State Bank of India partnership trend by key deal type (2014-YTD2018)
Table 7: State Bank of India capital raising volume and value trend (2014-YTD2018)
Table 8: State Bank of India capital raising by deal type (2014-YTD2018)
Table 9: State Bank of India divestments volume and value trend (2014-YTD2018)
Table 10: State Bank of India divestments activity by geography (2014-YTD2018)

List of Figures
Figure 1: State Bank of India M&A volume and value trend (2014-YTD2018)
Figure 2: State Bank of India M&A activity by geography (2014-YTD2018)
Figure 3: State Bank of India corporate venturing volume and value trend (2014-YTD2018)
Figure 4: State Bank of India corporate venturing by geography (2014-YTD2018)
Figure 5: State Bank of India partnership volume and value trend (2014-YTD2018)
Figure 6: State Bank of India partnership trend by key deal type (2014-YTD2018)
Figure 7: State Bank of India capital raising volume and value trend (2014-YTD2018)
Figure 8: State Bank of India capital raising by deal type (2014-YTD2018)
Figure 9: State Bank of India divestments volume and value trend (2014-YTD2018)
Figure 10: State Bank of India divestments by geography (2014-YTD2018)

★海外企業調査レポート[State Bank of India:企業のM&A・事業提携・投資動向]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Audentes Therapeutics Inc (BOLD):企業の財務・戦略的SWOT分析
    Summary Audentes Therapeutics Inc (Audentes) is a biotechnology company that focuses on the development and commercialization of gene therapy products for rare diseases. The company’s pipeline products include AT132, intended for the treatment of X-linked myotubular myopathy; AT982, for the treatmen …
  • Promore Pharma AB:製薬・医療:M&Aディール及び事業提携情報
    Summary Promore Pharma AB (Promore), formerly Pergamum AB is a biopharmaceutical company that develops peptide-based product candidates for local and topical treatment of infections and wounds. The company’s pipeline products include LL-37 and PXL01 therapeutic peptides. Its PXL01 is used for the pr …
  • Zumtobel Group AG (ZAG):企業の財務・戦略的SWOT分析
    Zumtobel Group AG (ZAG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • YTL Power International Bhd (YTLPOWR)
    YTL Power International Bhd (YTLPOWR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • Comstock Resources Inc (CRK):石油・ガス:M&Aディール及び事業提携情報
    Summary Comstock Resources Inc (Comstock) is an oil and gas company that acquires, develops, explores and produces oil and natural gas properties. The company provides oil and gas operations such as Eagle ford Shale, Haynesville Shale and Tuscaloosa Marine Shale in East Texas and North Louisiana, So …
  • Pressure Biosciences Inc:企業のM&A・事業提携・投資動向
    Pressure Biosciences Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Pressure Biosciences Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …
  • Vaccibody AS:製薬・医療:M&Aディール及び事業提携情報
    Summary Vaccibody AS (Vaccibody) is a vaccine company that provides discovery and development of novel immunotherapies, prophylactic and therapeutic vaccines. The company develops VB10.16, a DNA based immunotherapy targeting malignancies caused by human papilloma virus. It conducts exploratory safet …
  • Tesla Inc (TSLA):企業の財務・戦略的SWOT分析
    Tesla Inc (TSLA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Scientex Bhd (SCIENTX):企業の財務・戦略的SWOT分析
    Summary Scientex Bhd (Scientex) is a manufacturer and supplier of packaging products and component parts for automotive interior. The company operates through stretch and custom film, converting, specialty products and property development divisions. It offers lamination base, general, barrier and a …
  • Apollo Computing Laboratories (P) Ltd.:企業の戦略・SWOT・財務情報
    Apollo Computing Laboratories (P) Ltd. - Strategy, SWOT and Corporate Finance Report Summary Apollo Computing Laboratories (P) Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • MediaValet Inc.:戦略・SWOT・企業財務分析
    MediaValet Inc. - Strategy, SWOT and Corporate Finance Report Summary MediaValet Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • NIKE Inc:企業のM&A・事業提携・投資動向
    NIKE Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's NIKE Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital …
  • Eisai Inc:企業の戦略的SWOT分析
    Eisai Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • Indivior Plc (INDV):企業の財務・戦略的SWOT分析
    Indivior Plc (INDV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Laboratorios Liomont SA de CV:製薬・医療:M&Aディール及び事業提携情報
    Summary Laboratorios Liomont SA de CV (Liomont) is a pharmaceutical company that develops medication products. The company offers prescription medication products, biotech products and over the counter products. It provides drugs in various therapeutic areas including analgesics, antiparasitic, anti …
  • Bakkavor Group Limited:企業の戦略・SWOT・財務情報
    Bakkavor Group Limited - Strategy, SWOT and Corporate Finance Report Summary Bakkavor Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Pint Pharma GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary Pint Pharma GmbH (Pint Pharma), a subsidiary of Pint Pharma International SA, is a developer, manufacturer and marketer of originator drugs in rare disease, oncology and specialty conditions. The company offers its products in the form of tablets, injections, small compounds, drugs, implants …
  • Jubilee General Insurance Company Limited:企業の戦略・SWOT・財務情報
    Jubilee General Insurance Company Limited - Strategy, SWOT and Corporate Finance Report Summary Jubilee General Insurance Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW …
  • Catalyst Pharmaceuticals Inc (CPRX):製薬・医療:M&Aディール及び事業提携情報
    Summary Catalyst Pharmaceuticals Inc (Catalyst) is a biopharmaceutical company that develops prescription drugs targeting rare neurological and neuromuscular diseases. The company focuses on specific conditions such as infantile spasms, complex partial seizures, Lambert-Eaton myasthenic syndrome (LE …
  • JenaValve Technology Inc:医療機器:M&Aディール及び事業提携情報
    Summary JenaValve Technology Inc (JenaValve Technology), a subsidiary of JenaValve Technology GmbH, is a medical device company that develops and manufactures transcatheter aortic valve replacement (TAVR) systems for transapical and transfemoral implantation. The company’s TAVR system is an investig …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆